Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2014-04-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/jcbfm.2014.68PMID 24780897PMCID PMC4083382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain

  2014cited by this paper
• Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.

  2014cited by this paper
• 5‐HT radioligands for human brain imaging with PET and SPECT

  2013cited by this paper
• Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.

  2013cited by this paper
• Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36

  2013cited by this paper
• Direct comparison of [18F]MH.MZ and [18F]altanserin for 5‐HT2A receptor imaging with PET

  2013cited by this paper
• Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone

  2012cited by this paper
• Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography

  2012cited by this paper
• Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

  2012cited by this paper
• Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers

  2011cited by this paper
• Pilot study on receptor binding and serotonin sensitivity of [11C]CIMBI-36 in monkey brain

  2011cited by this paper
• A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](−)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum

  2010cited by this paper
• Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited

  2010cited by this paper
• Measuring Endogenous 5-HT Release by Emission Tomography: Promises and Pitfalls

  2010cited by this paper
• Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

  2010cited by this paper
• Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100, 907 PET and non-invasive kinetic analyses

  2010cited by this paper
• Psychedelics and schizophrenia.

  2009cited by this paper
• A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma.

  2009cited by this paper
• Impact of Image-Space Resolution Modeling for Studies with the High-Resolution Research Tomograph

  2008cited by this paper
• Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder

  2008cited by this paper
• Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.

  2008cited by this paper
• Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

  2006cited by this paper
• MR-based automatic delineation of volumes of interest in human brain PET images using probability maps

  2005cited by this paper
• [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge

  2004cited by this paper
• Quantification of 5-HT2A Receptors in the Human Brain Using [18F]Altanserin-PET and the Bolus/Infusion Approach

  2003cited by this paper
• Fenfluramine evokes 5‐HT2A receptor‐mediated responses but does not displace [11C]MDL 100907: Small animal PET and gene expression studies

  2003cited by this paper
• Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging

  2002cited by this paper
• Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions.

  2000cited by this paper
• Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions

  2000cited by this paper
• Simplified reference tissue model for PET receptor studies.

  1996cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper
• Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal Controls

  1995cited by this paper

• Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications.

  2026cites this paper
• Discordance Between Spatial and Population Correlations From Human Brain Imaging Data

  2025cites this paper
• Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

  2025cites this paper
• Pitfalls of mapping functional and molecular human brain imaging data from separate cohorts

  2025cites this paper
• [18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors.

  2025cites this paper
• Molecular brain imaging of psychedelic action.

  2025cites this paper
• Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases.

  2025cites this paper
• Imaging the 5-HT2C receptor with PET: Evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain

  2024cites this paper
• Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.

  2024cites this paper
• Mind-body medicine and altered states of consciousness in Homo

  2024cites this paper
• Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics

  2024cites this paper
• Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans

  2024cites this paper
• Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research.

  2024cites this paper
• Hominin musical sound production: palaeoecological contexts and self domestication

  2024cites this paper
• Exploring mechanisms of psychedelic action using neuroimaging

  2024cites this paper
• Multimodal brain age prediction using machine learning: combining structural MRI and 5-HT2AR PET-derived features

  2024cites this paper
• 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review

  2023cites this paper
• Neuroimaging in psychedelic drug development: past, present, and future

  2023cites this paper
• Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms

  2023cites this paper
• Concise and Scalable Radiosynthesis of (+)-[18F]MDL100907 as a Serotonin 5-HT2A Receptor Antagonist for PET

  2023cites this paper
• Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single‐photon emission computed tomography (SPECT) studies

  2023cites this paper
• Hallucinogenic activity, neurotransmitters release, anxiolytic and neurotoxic effects in Rat's brain following repeated administration of novel psychoactive compound 25B-NBOMe.

  2023cites this paper
• The association between brain serotonin 2A receptor binding and neuroticism in healthy individuals: A Cimbi database independent replication study

  2023cites this paper
• Animal Behavior in Psychedelic Research

  2022cites this paper
• More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics

  2022cites this paper
• Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals

  2022cites this paper
• The promises and perils of psychedelic pharmacology for psychiatry

  2022cites this paper
• Serotonin Receptors and Antidepressants: Neuroimaging Findings from Preclinical and Clinical Research

  2022cites this paper
• Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience

  2021cites this paper
• NRM 2021 Abstract Booklet

  2021cites this paper
• 25CN‐NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor

  2021cites this paper
• Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

  2021cites this paper
• Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging.

  2021cites this paper
• 25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C. elegans—Structure Determination and Synthesis of the Most Abundant Metabolites

  2021cites this paper
• Translational PET imaging applications for brain circuit mapping and manipulation with transgenic tools.

  2021cites this paper
• Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals

  2021cites this paper
• The study of noninvasive brain stimulation using molecular brain imaging: A systematic review

  2020cites this paper
• Molecular neuroimaging of the serotonergic system with Positron Emission Tomography

  2020cites this paper
• A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.

  2020cites this paper
• Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans

  2020cites this paper
• Imaging of the Serotonin System: Radiotracers and Applications in Memory Disorders

  2020cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Blocking of efflux transporters in rats improves translational validation of brain radioligands

  2020cites this paper
• NBOMes–Highly Potent and Toxic Alternatives of LSD

  2020cites this paper
• The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH.

  2020cites this paper
• Sex and the serotonergic underpinnings of depression and migraine.

  2020cites this paper
• Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

  2020cites this paper
• Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels

  2020influential citation
• Dark Classics in Chemical Neuroscience: NBOMes.

  2019cites this paper
• Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study

  2019cites this paper
• Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

  2019cites this paper
• Measuring endogenous changes in serotonergic neurotransmission with [11C]Cimbi-36 positron emission tomography in humans

  2019cites this paper
• Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain

  2019cites this paper
• In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.

  2019cites this paper
• Human biodistribution and radiation dosimetry of the 5-HT2A receptor agonist Cimbi-36 labeled with carbon-11 in two positions

  2019cites this paper
• Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development

  2019cites this paper
• Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain

  2019cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• University of Groningen Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers

  2019cites this paper
• Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge

  2019cites this paper
• Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging

  2018cites this paper
• Nuclear medicine of the cerebellum.

  2018cites this paper
• Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

  2018cites this paper
• Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD.

  2018cites this paper
• PET-MR Attenuation Correction in Dynamic Brain PET Using [11C]Cimbi-36: A Direct Comparison With PET-CT

  2018influential citation
• PET Imaging of the 5-HT 2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function

  2018cites this paper
• Cerebral serotonin release correlates with [11C]AZ10419369 PET measures of 5-HT1B receptor binding in the pig brain

  2018cites this paper
• Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment

  2018cites this paper
• 5-HT 2A Receptors and BDNF Regulation: Implications for Psychopathology

  2018cites this paper
• Automatic delineation of brain regions on MRI and PET images from the pig.

  2018cites this paper
• In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.

  2017cites this paper
• Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands

  2017cites this paper
• Effects of LSD on music-evoked brain activity

  2017cites this paper
• Development of 18F-labeled agonist radioligands for PET imaging of the high-affinity state of cerebral dopamine D2/3 receptors

  2017cites this paper
• PET studies on the mechanisms of action of antidepressant and antipsychotic drugs

  2017cites this paper
• Perception is in the Details: A Predictive Coding Account of the Psychedelic Phenomenon

  2017cites this paper
• Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain

  2017cites this paper
• Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150.

  2017cites this paper
• Metabolic fate and detectability of the new psychoactive substances 2‐(4‐bromo‐2,5‐dimethoxyphenyl)‐N‐[(2‐methoxyphenyl)methyl]ethanamine (25B‐NBOMe) and 2‐(4‐chloro‐2,5‐dimethoxyphenyl)‐N‐[(2‐methoxyphenyl)methyl]ethanamine (25C‐NBOMe) in human and rat urine by GC–MS, LC–MSn, and LC–HR–MS/MS approa

  2017cites this paper
• Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

  2017cites this paper
• Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors

  2017cites this paper
• The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions

  2017cites this paper
• Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

  2017cites this paper
• Serotonin and brain function: a tale of two receptors

  2017influential citation
• Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [18F]altanserin

  2016cites this paper
• Convergent 18F-labeling and evaluation of N-benzyl-phenethylamines as 5-HT2A receptor PET ligands.

  2016cites this paper
• The Center for Integrated Molecular Brain Imaging (Cimbi) database

  2016cites this paper
• Metabolic Fate of Hallucinogenic NBOMes.

  2016cites this paper
• 5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism.

  2016cites this paper
• Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases

  2016cites this paper
• LSD modulates music-induced imagery via changes in parahippocampal connectivity.

  2016cites this paper
• Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.

  2016cites this paper
• LSD alters eyes‐closed functional connectivity within the early visual cortex in a retinotopic fashion

  2016cites this paper
• Application of cross-species PET imaging to assess neurotransmitter release in brain

  2015cites this paper
• (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.

  2015cites this paper
• Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.

  2015cites this paper
• Impact of image-based motion correction on dopamine D3/D2 receptor occupancy—comparison of groupwise and frame-by-frame registration approaches

  2015cites this paper
• Current radiosynthesis strategies for 5-HT2A receptor PET tracers.

  2015cites this paper
• Development of 18 F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

  2014cites this paper
• Validation of scatter simulation in 3D and count-rate dependent component-based normalization for the HRRT

  2014cites this paper